Jade Biosciences, Inc. (JBIO) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $88.44M | +27.5% |
| 2024 | $69.39M | +195.4% |
| 2023 | $23.49M | +4.9% |
| 2022 | $22.40M | -58.7% |
| 2021 | $54.20M | +1085.2% |
| 2020 | $4.57M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $88.44M | +27.5% |
| 2024 | $69.39M | +195.4% |
| 2023 | $23.49M | +4.9% |
| 2022 | $22.40M | -58.7% |
| 2021 | $54.20M | +1085.2% |
| 2020 | $4.57M | — |